Aquestive director granted 50,500 stock options
Aquestive Therapeutics director Gregory B. Brown reported an equity compensation award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aquestive Therapeutics director Gregory B. Brown reported an equity compensation award. He received a grant of stock options covering 50,500 shares of Common Stock at an exercise price of $3.99 per share.
The options vest 100% on June 10, 2027, subject to his continuous service with the company through that date. Following this report, he directly holds 75,085 shares of Common Stock and the newly granted 50,500 stock options.
Insider Trade Summary
Grant/Award: 50,500 shares
Grant/Award
2 txns
Insider
BROWN GREGORY B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Purchase) | 50,500 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Purchase) — 50,500 contracts (Direct);
Common Stock — 75,085 shares (Direct)
Footnotes (1)
- F1. The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date.
Key Figures
Common shares held: 75,085 shares
Options granted: 50,500 options
Exercise price: $3.99 per share
+2 more
5 metrics
Common shares held
75,085 shares
Directly owned after reported transactions
Options granted
50,500 options
Stock Option (Right to Purchase) grant on Common Stock
Exercise price
$3.99 per share
Conversion or exercise price of the stock options
Vesting date
June 10, 2027
100% of underlying shares vest on this date
Expiration date
June 10, 2036
Stock options expiration
Key Terms
Stock Option (Right to Purchase), Common Stock, vesting, exercise price
4 terms
Stock Option (Right to Purchase) financial
"security_title: "Stock Option (Right to Purchase)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vesting financial
"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "3.9900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Gregory B. Brown report at Aquestive Therapeutics (AQST)?
Gregory B. Brown reported receiving a stock option grant at Aquestive Therapeutics. The award covers 50,500 options on Common Stock as compensation, not an open-market purchase or sale, and reflects an increase in his potential future ownership if the options are exercised.
How many stock options did Gregory B. Brown receive from Aquestive Therapeutics (AQST)?
He received a grant of 50,500 stock options. Each option relates to one share of Common Stock and carries an exercise price of $3.99 per share, providing potential future equity if the company’s share price exceeds that level after vesting.
What is the vesting schedule for Gregory B. Brown’s new AQST stock options?
The options vest 100% on June 10, 2027. Vesting is conditioned on Dr. Brown’s continuous service with Aquestive Therapeutics from the grant date through that vesting date, aligning the award with his ongoing role at the company.
What are Gregory B. Brown’s reported holdings in Aquestive Therapeutics (AQST) after this filing?
After this filing, he directly holds 75,085 shares of Common Stock and 50,500 stock options. The options are exercisable at $3.99 per share after vesting, which could increase his ownership if exercised in the future.
Is Gregory B. Brown’s AQST stock option grant an open-market buy or sell?
No, the transaction is a stock option grant categorized as a grant, award, or other acquisition. It represents equity-based compensation from Aquestive Therapeutics rather than an open-market purchase or sale of existing shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates